Table 2 Major adverse events (MAEs) and the individual MAE components among patients who have undergone carotid endarterectomy, according to diabetes status
| Â | Within 30-day outcomes after CEA | Within 4-year outcomes after CEAa | ||||||
|---|---|---|---|---|---|---|---|---|
Total (n = 675) | DM (n = 265) | Non-DM (n = 410) | P-value | Total (n = 675) | DM (n = 265) | Non-DM (n = 410) | P-value | |
MAE | 15 (2.2) | 7 (2.6) | 8 (2.0) | 0.552 | 85 (12.6) | 42 (15.8) | 43 (10.5) | 0.040 |
Any stroke | 9 (1.3) | 4 (1.5) | 5 (1.2) | 0.743 | 30 (4.4) | 19 (7.2) | 11 (2.7) | 0.006 |
 Major | 1 (0.1) | 0 | 1 (0.2) | 0.999 | 6 (0.9) | 2 (0.8) | 4 (1.0) | 0.999 |
 Minor | 8 (1.2) | 4 (1.5) | 4 (1.0) | 0.718 | 24 (3.6) | 17 (6.4) | 7 (1.7) | 0.001 |
MI | 2 (0.3) | 2 (0.8) | 0 | 0.154 | 2 (0.3) | 2 (0.8) | 0 | 0.154 |
Death | 4 (0.6) | 1 (0.4) | 3 (0.7) | 0.999 | 59 (8.7) | 25 (9.4) | 34 (8.3) | 0.608 |